<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00840229</url>
  </required_header>
  <id_info>
    <org_study_id>S-08546</org_study_id>
    <secondary_id>REK</secondary_id>
    <secondary_id>Interne tjenester</secondary_id>
    <secondary_id>IT-avdelingen</secondary_id>
    <secondary_id>Rikshospitalet HF</secondary_id>
    <nct_id>NCT00840229</nct_id>
  </id_info>
  <brief_title>Rotator Interval and Intra-articular Corticosteroid Injection for Frozen Shoulder</brief_title>
  <official_title>Rotator Interval and Intra-articular Corticosteroid Injection for Adhesive Capsulitis (Frozen Shoulder): a Randomised, Double Blind, Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare ultrasound guided capsular corticosteroid injection
      into the rotator interval/anterior capsule and the GH joint with ultrasound guided
      corticosteroid injection into the GH joint only. Both methods will be compared with placebo
      injections.

      Primary outcome measure: pain reduction at week 6 Secondary outcome measures: improvement of
      function (SPADI, Life quality, ROM).

      0-hypothesis: no difference between the methods.

      The investigators want to find out if the clinical effect of the combined capsular and
      intra-articular injections are better than placebo and better that intra-articular injections
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      3 groups, 50 patients in each, follow-up visits after 3, 6, 12 and 26 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>2-3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Function (ROM, SPADI), Life quality</measure>
    <time_frame>2-3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Adhesive Capsulitis</condition>
  <arm_group>
    <arm_group_label>1 capsular &amp; intra-articular</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>corticosteroid injection (Triamcinolone) in capsule/rotator interval and intra-articular</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 intra-articular</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>corticosteroid injection (Triamcinolone) intra-articular placebo injection (Lidocaine) in capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo injections (Lidocaine) in capsule and intra-articular</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone hexacetonide</intervention_name>
    <description>20 mg</description>
    <arm_group_label>3 placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone hexacetonide</intervention_name>
    <description>1 ml (20 mg) + 6 ml Lidocaine 10 mg/ml</description>
    <arm_group_label>1 capsular &amp; intra-articular</arm_group_label>
    <arm_group_label>2 intra-articular</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pain and stiffness in one shoulder 1 - 6 months

          -  Restriction of passive ROM; &gt;= 30 degrees in two or more planes compared to other
             shoulder

        Exclusion Criteria:

          -  Systemic inflammatory disease

          -  Corticosteroid treatment last 3 months

          -  Poorly controlled Diabetes mellitus

          -  Pregnancy

          -  Contraindications/allergy to corticosteroids and/or Lidocaine

          -  Severe infections

          -  Osteoarthritis of the shoulder

          -  Fractures of the shoulder

          -  Rotator cuff pathology causing pain or disability

          -  Fibromyalgia

          -  Not able to understand Norwegian
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tore A Prestgaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital of Vestfold</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vestfold Hospitalt Trust, Clinic Physical Medicine and Rehabilitation</name>
      <address>
        <city>Stavern</city>
        <zip>3294</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2009</study_first_submitted>
  <study_first_submitted_qc>February 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2009</study_first_posted>
  <last_update_submitted>November 24, 2013</last_update_submitted>
  <last_update_submitted_qc>November 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sykehuset i Vestfold HF</investigator_affiliation>
    <investigator_full_name>Tore Prestegaard</investigator_full_name>
    <investigator_title>MD, consultant physician</investigator_title>
  </responsible_party>
  <keyword>adhesive capsulitis</keyword>
  <keyword>corticosteroids</keyword>
  <keyword>injection</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

